Overview
In early 2026, the Telangana government announced that cancer will be treated as a notifiable disease. This move creates the state’s first comprehensive cancer registry, aiming to capture every diagnosed case across public and private facilities.
Key Developments
- All hospitals, pathology labs and diagnostic centres must upload case details to an online portal within a month of diagnosis.
- The data will be validated by the MNJ Cancer Hospital and forwarded to the National Cancer Registry Programme under ICMR.
- Implementation began on 6 April 2026, with training for district health officers and regular review meetings.
- Simultaneously, the state expanded Day Care Cancer Centres to 34 district hospitals, bringing basic oncology services closer to patients.
Important Facts from the Telangana Cancer Atlas
- Between April 2020 and September 2025, 1,00,294 unique patients received cancer treatment under the Aarogyasri scheme, averaging 18,235 patients per year.
- 34,256 patients were treated at MNJ Cancer Hospital, making it the largest single centre.
- Private hospitals handled 53.4% of cases, while government hospitals treated 43.4%.
- Hyderabad recorded the highest number of treated patients (12,517), but adjusted incidence was highest in Hanumakonda (79 per 1 lakh).
- Women comprised ≈60% of patients; breast and cervical cancers were the major contributors.
- Only one of four radiotherapy machines at MNJ is fully functional, yet it serves 400‑500 patients daily.
Exam Relevance
The initiative touches on several GS topics: health governance (GS3), public‑private partnership in healthcare (GS3), disease surveillance and data‑driven policy (GS3), and equitable access to specialised services (GS2: Polity). Understanding the role of Aarogyasri illustrates how state‑level insurance can reduce out‑of‑pocket expenditure, a recurring theme in health economics questions.
Way Forward
- Strengthen reporting mechanisms to avoid duplicate entries and ensure timely data capture.
- Upgrade infrastructure: procure additional radiotherapy machines and introduce advanced therapies like immunotherapy in public hospitals.
- Expand specialised oncology units beyond Hyderabad by establishing Regional Cancer Centres as planned for 2030.
- Use registry insights to target high‑incidence districts with screening, awareness and palliative‑care programmes.
- Continue capacity building for district health officers to sustain the notifiable disease reporting system.
Only when the data translates into more hospitals, trained specialists, and affordable advanced treatments will the crowds outside MNJ Cancer Hospital see real relief.